The Biosimilars Market in the United States is expanding as healthcare providers, pharmaceutical manufacturers, and regulatory authorities increasingly support the adoption of biosimilar medicines to improve access to advanced biological treatments. Market Overview The biosimilars market size is expected to grow from US$ 18,435.89 million in 2021 to US$ 1,36,069.53 million in 2028; it is...